Archive: 29/09/2014

Cells from placentas safe for patients with multiple sclerosis

Patients with Multiple Sclerosis (MS) were able to safely tolerate treatment with cells cultured from human placental tissue, according to a study published today in the journal Multiple Sclerosis and Related Disorders. The ...

Sep 29, 2014

Revolutionary hamstring tester will keep more players on the paddock

Elite sporting stars can assess and reduce their risk of a hamstring injury thanks to a breakthrough made by QUT researchers.

Sep 29, 2014

0

0

Health lessons provided by interactive media easier for youth to swallow

Lecturing teens to eat their vegetables and get more exercise may not motivate them to adopt healthier habits, as many parents know. But will members of the "Facebook generation" learn to eat their broccoli and take more ...

Sep 29, 2014

0

0

Study indicates exchange plans can vary widely on provider inclusion

A new study released today by the American Heart Association on the inclusion of cardiovascular and stroke providers by exchange health plans reveals that access to specialty physicians and facilities can vary widely based ...

Sep 29, 2014

Study investigates access to weight loss clubs for people with learning disabilities

A study aimed at improving access to weight loss clubs like Slimming World for people with learning disabilities, is underway by researchers from the University of Sheffield.

Sep 29, 2014

0

0

Is coconut oil good for you?

There is no consistent body of data that I am aware of to indicate that coconut oil has documented specific beneficial effects; hence, there is no data that I'm aware of to suggest people should go out of their way to consume ...

Sep 29, 2014

Early detection key to avoiding large Ebola outbreaks

Improved diagnosis of people with severe fevers is essential in the battle against the deadly Ebola virus, a study published in the Journal of Infection in Developing Countries has found.

Sep 29, 2014

0

0

Promising results shown with targeted approaches in subsets of non-small cell lung cancer

The BRAF inhibitor dabrafenib has significant anti-tumour activity in patients with advanced BRAF V600E mutant non-small cell lung cancer whose disease has progressed after chemotherapy, according to phase II data presented ...

Sep 29, 2014